Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?
Voelkel
N F
NF
Pulmonary Hypertension Center, University of Colorado Health Sciences Center, Denver, Colorado, USA. norbet.voelkel@uchsc.edu
Tuder
R M
RM
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002908:Chronic Disease; D004195:Disease Models, Animal; D016228:Endothelial Growth Factors / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism / Q000473:pathology; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D000860:Hypoxia / Q000473:pathology / Q000503:physiopathology*; D008168:Lung / Q000098:blood supply* / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008222:Lymphokines / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010100:Oxygen / Q000494:pharmacology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014661:Vasoconstriction / Q000502:physiology
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D010100:Oxygen